U.S. Army Medicine Leads In Infectious Disease Research
In 2004, U.S. Army Col. Jerome Kim, an infectious disease physician, flew to Bangkok to oversee a massive HIV vaccine study.

It was the opportunity of a lifetime-and the stakes were high. If successful, it could be the first vaccine to show even moderate protection against HIV infection—a  critical milestone in the fight against HIV.

Sponsored by the U.S. Army in partnership with the government of Thailand, the Phase III clinical trial known as RV144 followed 16,000 Thai volunteers. The results announced in 2009 "showed an efficacy rate of 31.2 percent in vaccine recipients," said Dr. Kim, now the Deputy Director of the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR).

"This achievement paved the way for us to learn more about the HIV virus, refine the vaccine and boost the immune response so the next generation of the vaccines will be more effective," he said.
Read more...